Obidoxime content in the brain tissue of rats intoxicated with organophosphate insecticide chlorfenvinphos after administration of toxogonin

Acta Toxicologica

Volumn 14, Issue 1-2, 2006, Pages 31-35

  Raszewski, Grzegorz ^a   Burda, Stanisław ^b  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b STATE RESEARCH INSTITUTE   (Poland)

Author keywords

Blood brain barrier; Chlorfenvinphos; Obidoxime; Organophosphate poisoning; Pharmacological effects

Indexed keywords

CLOFENVINFOS; OBIDOXIME; ORGANOPHOSPHATE INSECTICIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TISSUE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG PENETRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTOXICATION; ION PAIR CHROMATOGRAPHY; MALE; NONHUMAN; PH MEASUREMENT; QUANTITATIVE ANALYSIS; RAT; ULTRAVIOLET SPECTROSCOPY;

RATTUS;

EID: 34250336358     PISSN: 17316383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Jokanovic M, Stojiljkovic MP. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning. Eur J Pharmacol [in press], available online from 2006 Oct 11.
2. Kassa J. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 2002;40(6):803-16.
3. Johnson MK, Jacobsen D, Meredith TJ, Eyer P, Heath AJ, Ligtenstein DA, et al. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg Medicine 2000;12:22-37.
4. Helden van HPM, de Lange J, Busker RW, Melchers BPC. Therapy of organophosphate poisoning in the rat by direct effects of oximes unrelated to ChE reactivation. Arch Toxicol 1991;65:586-93.
5. Helden van HPM, Busker RW, Melchers BPC, Bruijnzeel PLB. Pharmacological effects of oximes: how relevant are they. Arch Toxicol 1996;70:779-86.
6. Besser R, Weilemann LS, Gutman L. Efficacy of obidoxime in human organophosphorus poisoning: determination by neuromuscular transmission studies. Muscle Nerve 1995;18:15-22.
7. Clement JG. Central activity of acetylcholinesterase oxime reactivators. Toxicol Appl Pharmacol 1992;12:104-9.
8. Ligtenstein DA, Moes GW, Kossen SP. In vivo distribution of organophosphate antidotes: autoradiography of [14C]HI-6 in the rat. Toxicol Appl Pharmacol 1988;92:324-9.
9. Helden van HPM, van der Wiel HJ, Zijlstra JJ, Melchers BPC, Busker RW. Comparison of the therapeutic effects and pharmacokinetics of HI-6, HLö-7, HGG-12, HGG-42 and obidoxime following non-reactivatable acetylcholinesterase inhibition in rats. Arch Toxicol 1994;68:224-30.
10. Lundy PM, Shih MT. Examination of the role of central cholinergic mechanisms in the therapeutic effects of HI-6 in organophosphate poisoning. J Neurochem 1983;40:1321-8.
11. Boskovic B, Tadic V, Kusic R. Reactivating and protective effects of pro-2-PAM in mice poisoned with paraoxon. Toxicol Appl Pharmacol 1980;55:32-6.
12. Ligtenstein DL, Kosen SP. Kinetic profile in blood and brain of the cholinesterase reactivating oxime HI-6 after intravenous administration to the rat. Fundam Appl Toxicol 1983;71:177-83.
13. Benschop HP, Kees AG, Konings SP, Kossen DA, Ligtenstein DA. Determination of some pyridinium aldoxime compouds by means of ion-pair reversed phase high-performance liquid chromatography: application in biological material. J Chromatogr 1981;225:107-14.
14. Grasshoff C, Thierman H, Gillessen T, Zilker T, Szinicz L. Internal standard high-performance liquid chromatography method for the determination of obidoxime in urine of organophosphate-poisoned patients. J Chromatogr Biomed Sci Appl 2001(2);53:203-8.